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OBJECTIVES We sought to determine whether the quality of life (QoL) is different in patients after aortic
valve replacement with mechanical prostheses or pulmonary autografts.
BACKGROUND Quality of life after mechanical valve replacement may be affected by the risk of thrombo-
embolism and anticoagulation, and after autograft implantation, by the risk of degeneration
and re-operation especially of the homograft.
METHODS Two groups of 40 patients each—one after the autograft procedure (group I) and one after
mechanical valve implantation (group II)—were matched for age, gender and length of
follow-up. At latest follow-up, all patients underwent routine echocardiography, the
short-form health survey (SF-36) QoL survey and an extensive psychological investigation.
RESULTS Patients with an autograft showed better QoL scales, as compared with mechanical valve
recipients. The difference was significant for both the physical (72.72 6 20.00 vs. 60.27 6
26.07, p 5 0.021) and psychological health sum scores (74.71 6 21.03 vs. 64.71 6 23.49, p 5
0.046) and for the subtests of physical functioning (73.72 6 22.44 vs. 62.77 6 25.42, p 5
0.049), physical pain (88.39 6 19.13 vs. 73.36 6 27.08, p # 0.006), general health perception
(64.37 6 17.88 vs. 51.86 6 22.86, p # 0.008) and health change (61.89 6 18.94 vs. 50.11 6
24.37, p 5 0.02). The QoL variables did not correlate to pressure gradients, ejection fraction
and New York Heart Association functional class. Psychometric tests revealed no meaningful
differences between the groups.
CONCLUSIONS This study provides some evidence that patients with pulmonary autografts have greater
benefit in terms of QoL, as compared with recipients of mechanical valve substitutes. (J Am
Coll Cardiol 2001;37:1963–6) © 2001 by the American College of Cardiology
Aortic valve replacement is a well-established treatment for
aortic valve disease. Conventionally, xenografts or mechan-
ical prostheses are used as substitutes. Mechanical prosthe-
ses are easily implanted and durable. Hemodynamic data,
however, are suboptimal, and life-long anticoagulation is
mandatory, rendering the patient with a constant risk of
bleeding and thromboembolism (1,2). Recipients of xeno-
grafts usually do not need anticoagulation, but are threat-
ened by the risk of degeneration increasing with time (3,4).
Since its introduction by Ross (5), the use of pulmonary
autografts for aortic valve replacement (Ross procedure) has
been increasingly accepted, because the graft provides ideal
properties regarding hemodynamic data, thromboembolism
and durability (6).
In contrast to earlier criteria for successful aortic valve
surgery (e.g., early and late mortality and absence of major
complications), more attention has recently been paid to
other outcome variables, such as quality of life (QoL).
Quality of life, applied as an indicator of health, is a
subjective evaluation of the patients’ state of health and has
not been previously investigated in patients who have had
the Ross procedure, to the best of our knowledge. The
36-item Short-Form Health Survey (SF-36) (7) is a psy-
chometric test with widespread international use for QoL
studies (8,9). Using this test battery, as well as additional
psychological tests, we compared patients after aortic valve
replacement with pulmonary autografts and mechanical
prostheses.
METHODS
Study group. This investigation was performed in patients
who had the Ross procedure (mean age 57.58 6 10.27
years, mean follow-up period 2.21 6 1.29 years; group I)
and in recipients of mechanical aortic valve prostheses
(mean age 59.18 6 10.39 years, mean follow-up period
1.86 6 0.69 years; group II). Each group consisted of 40
patients, with 29 men and 11 women. The patients’ medical
histories (e.g., anemia, angina pectoris, peripheral arterio-
sclerosis, dyspnea, hypotension, hypertension, diabetes mel-
litus, claudication, rhythm disorders, rheumatic diseases,
partial deafness, stroke, weak eyesight) preoperatively and at
latest follow-up were statistically insignificant (p # 0.05).
Group I patients exhibited a tendency toward a better, albeit
statistically insignificant (p . 0.05), preoperative New York
Heart Association (NYHA) functional class. The preoper-
ative left ventricular ejection fraction (EF) was not analyzed,
because the groups contained different numbers of patients
with aortic insufficiency; therefore, these values are not
comparable. Group II patients were under stable anti-
From the Departments of Cardiac Surgery and Anesthesiology, Medical University
of Lu¨beck, Lu¨beck, Germany.
Manuscript received November 10, 2000; revised manuscript received February 15,
2001, accepted February 26, 2001.
Journal of the American College of Cardiology Vol. 37, No. 7, 2001
© 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00
Published by Elsevier Science Inc. PII S0735-1097(01)01267-0
coagulation with phenprocoumon (Marcumar, Roche,
Grenzach-Wyhlen, Germany or Falithrom, Hexal, Holz-
kirchen, Germany). The reasons for choosing the substitute
were related to the preferences of the particular surgeon and
the referring cardiologist.
Surgical procedure. GROUP I. The pulmonary autograft
was implanted in the subcoronary position in 30 patients.
The full-root replacement technique was performed in two
patients, and the cylinder inclusion technique in eight
patients. Cryopreserved homografts were used for recon-
struction of the right ventricular outflow tract.
GROUP II. Mechanical aortic valves (CarboMedics Canada
Ltd., Calgary, Alberta, Canada) were implanted in 31
patients (diameters: 2 3 19, 5 3 21, 12 3 23, 8 3 25, 3 3
27 mm and a 23-mm composite graft), whereas St. Jude
Medical valves (St. Jude Medical, Inc., St. Paul, Minnesota)
were used in nine patients (diameters: 3 3 21, 3 3 23, 2 3
25 and 1 3 27 mm).
Study design. The study was approved by our Institutional
Ethics Committee for Human Investigation. Written, in-
formed consent was obtained from each patient. For all
patients who underwent the Ross procedure between 1991 and
1997, corresponding mechanical valve recipients were sought
in our database. The matching criteria were age, length of
follow-up and gender. Exclusion variables were age ,18 years,
first language other than German, psychiatric diseases, dialysis
and malignancies. Forty matched pairs remained. All patients
underwent clinical and routine echocardiography with a
2.5-MHz transducer (Sonos 2500 System, Hewlett Packard,
Andover, Massachusetts). Aortic regurgitation was assessed by
color flow Doppler techniques and graded as follows, using the
ratio of jet height/left ventricular outflow tract height (10):
ratio 1% to 24% 5 grade I; 25% to 46% 5 grade II; 47% to
64% 5 grade III; and $65% 5 grade IV. Pressure gradients
across the aortic valve were calculated by applying the modified
Bernoulli equation: Dp 5 4n2. The German version of the
SF-36 QoL evaluation (8) was performed, in addition to
psychometric questionnaires like the Freiburg Personality In-
ventory (FPI-R) (11), which assesses 10 personality traits in
addition to extraversion and neuroticism; the Stress-Recovery
Questionnaire (EBF-24) (12), which assesses the current
stress-recovery state; the Stress-Coping Questionnaire (SVF-
66) (13), which assesses the strategy someone will probably use
if he or she is disturbed by anything or anyone; and a personal
questionnaire for assessment of the patient’s educational level.
Trained interviewers performed all investigations.
Statistical analysis. Data were analyzed for each variable
by means of the t test or Fisher exact test. Because the
groups differed regarding the personality trait of “social
desirability,” the SF-36 scales were analyzed by means of
analysis of covariance, using the FPI-R scale as the covari-
ate. The data are expressed as the mean value 6 standard
deviation. Adjusted mean values are reported if analysis of
covariance was performed, and p # 0.05 was considered
statistically significant. Statistical analysis was performed
without alpha adjustments; therefore, the results are con-
sidered mainly explorative (14). Correlations were calculated
according to Pearson or, in case of ordinal data, Spearman.
All statistical analyses were performed with the computer
program SPSS for Windows (SPSS version 8.0, SPSS Inc,
Chicago, Illinois).
RESULTS
The differences between the two groups, in terms of age,
follow-up period, gender, education and medical history,
were negligible.
QoL. For the SF-36 test battery, the patients with autografts
had better values, as compared with the mechanical valve
recipients (Fig. 1). The differences were significant for both the
physical health sum score (72.72 6 20.00 vs. 60.27 6 26.07,
p 5 0.021) and the psychological health sum score (74.71 6
21.03 vs. 64.71 6 23.49, p 5 0.046), as well as for the subtests
of physical functioning (73.72 6 22.44 vs.62.77 6 25.42, p 5
0.049), physical pain (88.39 6 19.13 vs. 73.36 6 27.08, p #
0.006), general health perception (64.37 6 17.88 vs. 51.86 6
22.86, p # 0.008) and health change (61.89 6 18.94 vs.
50.11 6 24.37, p 5 0.02). The correlations of the SF-36 scales
with EF, pressure gradients and NYHA functional class were
not significant for either the patient subgroups or the total
group.
Psychometric questionnaires. There were no differences
between the groups in the 35 scales of the standardized
inventories—EBF-24, SVF-66 and FPI-R—except in the
FPI-R scales of “health worries” (group I: 7.28 6 3.55;
group II: 8.85 6 2.78, p 5 0.03) and “social desirability”
(group I: 5.05 6 2.72; group II: 3.80 6 2.72, p 5 0.04). In
EBF-24, group I had significantly better values in the scale
of “physical recovery” (group I: 3.43 6 1.10; group II:
2.85 6 1.43, p 5 0.05).
Clinical investigation and echocardiography. Group I
patients had a significantly better NYHA functional class
than group II patients (class I: 37 vs. 24 patients; class II: 2
vs. 12; and class III: 1 vs. 3; p 5 0.004). The EF was
significantly higher in group I (63.03 6 9.2 vs. 52.78 6
11.85, p , 0.001), with lower maximal and mean pressure
gradients across the neoaortic valve (6.15 6 2.37 vs.
22.83 6 12.85 mm Hg, p , 0.001; and 3.62 6 1.40 vs.
13.23 6 7.28 mm Hg, p , 0.001, respectively). The
correlations between EF and these maximal and mean
pressure gradients in the total cohort were r 5 0.239 (p 5
0.019) and r 5 0.368 (p 5 0.008), respectively. In group I,
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1964 No¨tzold et al. JACC Vol. 37, No. 7, 2001
QoL in Aortic Valve Replacement June 1, 2001:1963–6
no patient had more than trivial aortic regurgitation, except
for two patients with mild aortic insufficiency. There was no
meaningful mean pressure gradient (6.09 6 3.14 mm Hg)
or insufficiency across the homograft in group I patients. In
addition, no irregular valve function or paravalvular leakage
was observed in group II patients.
DISCUSSION
This study provides evidence that patients who had the
pulmonary autograft procedure have greater benefit in terms
of QoL, as compared with recipients of mechanical valve
prostheses.
QoL in general. Aortic valve replacement often results in a
substantially improved outcome for severely ill patients.
Valve substitutes and therapeutic strategies have signifi-
cantly progressed in design and function over time. Thus,
now, mortality and morbidity are no longer the only criteria
for decision-making and for choosing the heart valve sub-
stitute; increasingly, other aspects (i.e., QoL) have greater
importance. This has not been previously addressed for the
pulmonary autograft procedure, especially in comparison to
standard mechanical valve replacement. We used the well-
validated and often applied SF-36 for the assessment of
QoL, which includes four accepted components (15,16): 1)
mental state, meaning the emotionality of the patient, with
a wide range of aspects like depression, fear and mood; 2)
physical state, meaning the patient’s somatic complaints; 3)
social relations, meaning its extent of impact on the patient’s
state of health and interpersonal relationships; and 4)
functional competence, meaning the patient’s mental and
physical performance and their capacity to withstand the
stress of everyday life. In our study, we found an improved
QoL in patients who had the Ross procedure, as compared
with mechanical valve recipients. Although the pulmonary
autograft is a biologic substitute, it does not seem to be
similar to bioprostheses with regard to QoL. Myken et al.
(17) could not demonstrate any difference in QoL for
patients with bioprostheses versus those with mechanical
heart valves, and surprisingly, patients with mechanical
heart valves were more concerned about re-operation, as
compared with those with bioprostheses. This question of
fear of re-operation was not part of our questionnaire, but
the patients who had the Ross procedure were thoroughly
informed about a possible re-operation, which predomi-
nately occurs in the long-term postoperative period. Cham-
bers et al. (18) reported a freedom from re-operation rate of
85% in 25 years. Therefore, the risk of re-operation seems to
have no decisive influence on QoL in these patients if the
mental health sum scale is considered. Also, the subscales of
mental health showed better values in those who had the
Ross procedure as compared with those who had mechan-
ical valve surgery (p 5 NS).
QoL and left ventricular function. With regard to the
better postoperative EF of the patients with autografts, we
Figure 1. The Short Form Health Survey values of both groups. The physical and mental health sum scales and their subtests are given. *p # 0.05 and
†p # 0.01 by analysis of covariance, using the Freibury Personality Inventory scale of “social desirability” as the covariate.
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cannot exclude the possibility that the surgeon may have
been influenced in his decision about which operative
procedure to perform, according to the general preoperative
left ventricular function, in the sense that, for the technically
difficult and time-consuming Ross procedure, “better” pa-
tients had been chosen. In contrast, it is known that the
capability of the left ventricle to remodel again is substan-
tially dependent on the hemodynamic characteristics of the
valve. Therefore, it is reasonable to assume that the higher
EF at follow-up in the patients with autografts, consistent
with previous studies (19), reflects, at least in part, the better
hemodynamic properties of this graft. However, there were
no meaningful correlations of SF-36 scales with either the
EF or pressure gradients or NYHA functional class. Thus,
the differences in QoL are based on other issues regarding
the implanted substitute.
Mental health. Mechanical valve recipients are perma-
nently reminded on their disease by valve sounds, blood
sampling for anticoagulation control and life-style and
professional limitations, due to bleeding risks, probably
leading to an impaired health perception. In addition, the
fear of the constant risk of bleeding and thromboembolism
may have a negative effect on the mental health of these
patients. Whether the valve sound has any effect on the
measured subsets is speculative, as Thulin et al. (20) and
Myken et al. (17) did not find the valve sound to be a
disturbing factor for QoL. In comparison, patients who had
the Ross procedure had a significantly increased health
perception. Some patients claim to have almost forgotten
about their operation. This might also have contributed to
their better mental health.
Physical health. A more pronounced difference between
patients with autografts and those with mechanical valve
surgery was found in our study when physical health was
considered. In particular, the subscale of physical pain was
significantly improved after the Ross procedure, indicating that
these patients feel healthier and notice a benefit from a better
NYHA functional class. Whether this relates to the lower
transaortic pressure gradient or higher EF seems to be ques-
tionable, because we could not find a meaningful correlation
between these variables and SF-36 values. Theoretically, the
fact that physical activities are restricted in mechanical valve
recipients was contributing to these differences. In conclusion,
the better outcome in terms of QoL adds to the well-known
advantages of the autograft procedure.
Study limitations. This study is not randomized, nor
prospective. In addition, there are no ratings of QoL before
the operation. Therefore, one cannot finally conclude that
group differences in QoL scores are the result of different
developments in the two patient groups after their opera-
tion. The results reflect differences in the state of QoL
nearly two years after the operation in subjects who were
carefully matched in terms of age, gender and length of
follow-up and who were similar with respect to their
preoperative functional state, educational level and psycho-
logical traits concerning their personality, as well as several
other variables (see Methods section). In particular, the
matching of age and gender is important, because these
factors have a great impact on the SF-36 score (9). How-
ever, these factors must be considered in assessing the results
of the study; furthermore, we cannot exclude some bias
related to the selection of the operative technique made by
the referring physician, which may have some influence on
QoL, even two years later.
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